Subperiosteal injections during facial soft tissue filler injections—Is it possible?

Tatjana Pavicic, Mariya Yankova, Thilo L. Schenck, Konstantin Frank, David L. Freytag, Jonathan M Sykes, Jeremy B. Green, Hassan Hamade, Gabriela Casabona, Sebastian Cotofana

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: It can be hypothesized that safety during soft tissue filler injection could be enhanced if the product could be positioned between the periosteum and the bone surface i.e. subperiosteal. Aim: This study investigated the feasibilityof subperiosteal injections. Patients/Methods: We analysed 126 injection procedures performed in seven Caucasian body donors (4 males, 3 females) with a mean age of 75.29 ± 4.95 years [range: 70 – 87] and a mean body mass index of 23.53 ± 3.96 kg/m2 [range: 16.46 – 32.23]. The injection procedures were performed in the forehead, scalp, zygomatic arch and the mandible bilaterally. Injection procedures were conducted using 25G, 27G and 30G sharp-tip needles (TSK Laboratory, Tochigi, Japan) and at various angles from the bone surface measured with a goniometer: 90 degrees (perpendicular), 45 degrees and 10 degrees (as tangential as possible to bone surface). Results: Cadaveric dissections of the injection sites showed that no product was located deep to the periosteum in any of the investigated regions. This indicates that all performed injection procedures positioned the product superficial to the periosteum (100%) with a zero-success rate of subperiosteal injections. Conclusion: In the setting of this cadaveric investigation, despite varying needle size and injection angle, subperiosteal injection could not be achieved. This indicates that the product can spread uncontrolled into more superficial layers yielding an increased risk for adverse aesthetic and vascular events.

Original languageEnglish (US)
JournalJournal of Cosmetic Dermatology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Injections
Periosteum
Bone and Bones
Needles
Zygoma
Forehead
Scalp
Mandible
Esthetics
Blood Vessels
Dissection
Japan
Body Mass Index
Tissue Donors
Safety

Keywords

  • facial anatomy
  • injections
  • layers of the face
  • soft tissue fillers
  • subperiosteal

ASJC Scopus subject areas

  • Dermatology

Cite this

Pavicic, T., Yankova, M., Schenck, T. L., Frank, K., Freytag, D. L., Sykes, J. M., ... Cotofana, S. (Accepted/In press). Subperiosteal injections during facial soft tissue filler injections—Is it possible? Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.13073

Subperiosteal injections during facial soft tissue filler injections—Is it possible? / Pavicic, Tatjana; Yankova, Mariya; Schenck, Thilo L.; Frank, Konstantin; Freytag, David L.; Sykes, Jonathan M; Green, Jeremy B.; Hamade, Hassan; Casabona, Gabriela; Cotofana, Sebastian.

In: Journal of Cosmetic Dermatology, 01.01.2019.

Research output: Contribution to journalArticle

Pavicic, T, Yankova, M, Schenck, TL, Frank, K, Freytag, DL, Sykes, JM, Green, JB, Hamade, H, Casabona, G & Cotofana, S 2019, 'Subperiosteal injections during facial soft tissue filler injections—Is it possible?', Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.13073
Pavicic, Tatjana ; Yankova, Mariya ; Schenck, Thilo L. ; Frank, Konstantin ; Freytag, David L. ; Sykes, Jonathan M ; Green, Jeremy B. ; Hamade, Hassan ; Casabona, Gabriela ; Cotofana, Sebastian. / Subperiosteal injections during facial soft tissue filler injections—Is it possible?. In: Journal of Cosmetic Dermatology. 2019.
@article{1a57fffe0be64b2284da776bed732dcd,
title = "Subperiosteal injections during facial soft tissue filler injections—Is it possible?",
abstract = "Background: It can be hypothesized that safety during soft tissue filler injection could be enhanced if the product could be positioned between the periosteum and the bone surface i.e. subperiosteal. Aim: This study investigated the feasibilityof subperiosteal injections. Patients/Methods: We analysed 126 injection procedures performed in seven Caucasian body donors (4 males, 3 females) with a mean age of 75.29 ± 4.95 years [range: 70 – 87] and a mean body mass index of 23.53 ± 3.96 kg/m2 [range: 16.46 – 32.23]. The injection procedures were performed in the forehead, scalp, zygomatic arch and the mandible bilaterally. Injection procedures were conducted using 25G, 27G and 30G sharp-tip needles (TSK Laboratory, Tochigi, Japan) and at various angles from the bone surface measured with a goniometer: 90 degrees (perpendicular), 45 degrees and 10 degrees (as tangential as possible to bone surface). Results: Cadaveric dissections of the injection sites showed that no product was located deep to the periosteum in any of the investigated regions. This indicates that all performed injection procedures positioned the product superficial to the periosteum (100{\%}) with a zero-success rate of subperiosteal injections. Conclusion: In the setting of this cadaveric investigation, despite varying needle size and injection angle, subperiosteal injection could not be achieved. This indicates that the product can spread uncontrolled into more superficial layers yielding an increased risk for adverse aesthetic and vascular events.",
keywords = "facial anatomy, injections, layers of the face, soft tissue fillers, subperiosteal",
author = "Tatjana Pavicic and Mariya Yankova and Schenck, {Thilo L.} and Konstantin Frank and Freytag, {David L.} and Sykes, {Jonathan M} and Green, {Jeremy B.} and Hassan Hamade and Gabriela Casabona and Sebastian Cotofana",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/jocd.13073",
language = "English (US)",
journal = "Journal of Cosmetic Dermatology",
issn = "1473-2130",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Subperiosteal injections during facial soft tissue filler injections—Is it possible?

AU - Pavicic, Tatjana

AU - Yankova, Mariya

AU - Schenck, Thilo L.

AU - Frank, Konstantin

AU - Freytag, David L.

AU - Sykes, Jonathan M

AU - Green, Jeremy B.

AU - Hamade, Hassan

AU - Casabona, Gabriela

AU - Cotofana, Sebastian

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: It can be hypothesized that safety during soft tissue filler injection could be enhanced if the product could be positioned between the periosteum and the bone surface i.e. subperiosteal. Aim: This study investigated the feasibilityof subperiosteal injections. Patients/Methods: We analysed 126 injection procedures performed in seven Caucasian body donors (4 males, 3 females) with a mean age of 75.29 ± 4.95 years [range: 70 – 87] and a mean body mass index of 23.53 ± 3.96 kg/m2 [range: 16.46 – 32.23]. The injection procedures were performed in the forehead, scalp, zygomatic arch and the mandible bilaterally. Injection procedures were conducted using 25G, 27G and 30G sharp-tip needles (TSK Laboratory, Tochigi, Japan) and at various angles from the bone surface measured with a goniometer: 90 degrees (perpendicular), 45 degrees and 10 degrees (as tangential as possible to bone surface). Results: Cadaveric dissections of the injection sites showed that no product was located deep to the periosteum in any of the investigated regions. This indicates that all performed injection procedures positioned the product superficial to the periosteum (100%) with a zero-success rate of subperiosteal injections. Conclusion: In the setting of this cadaveric investigation, despite varying needle size and injection angle, subperiosteal injection could not be achieved. This indicates that the product can spread uncontrolled into more superficial layers yielding an increased risk for adverse aesthetic and vascular events.

AB - Background: It can be hypothesized that safety during soft tissue filler injection could be enhanced if the product could be positioned between the periosteum and the bone surface i.e. subperiosteal. Aim: This study investigated the feasibilityof subperiosteal injections. Patients/Methods: We analysed 126 injection procedures performed in seven Caucasian body donors (4 males, 3 females) with a mean age of 75.29 ± 4.95 years [range: 70 – 87] and a mean body mass index of 23.53 ± 3.96 kg/m2 [range: 16.46 – 32.23]. The injection procedures were performed in the forehead, scalp, zygomatic arch and the mandible bilaterally. Injection procedures were conducted using 25G, 27G and 30G sharp-tip needles (TSK Laboratory, Tochigi, Japan) and at various angles from the bone surface measured with a goniometer: 90 degrees (perpendicular), 45 degrees and 10 degrees (as tangential as possible to bone surface). Results: Cadaveric dissections of the injection sites showed that no product was located deep to the periosteum in any of the investigated regions. This indicates that all performed injection procedures positioned the product superficial to the periosteum (100%) with a zero-success rate of subperiosteal injections. Conclusion: In the setting of this cadaveric investigation, despite varying needle size and injection angle, subperiosteal injection could not be achieved. This indicates that the product can spread uncontrolled into more superficial layers yielding an increased risk for adverse aesthetic and vascular events.

KW - facial anatomy

KW - injections

KW - layers of the face

KW - soft tissue fillers

KW - subperiosteal

UR - http://www.scopus.com/inward/record.url?scp=85069931848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069931848&partnerID=8YFLogxK

U2 - 10.1111/jocd.13073

DO - 10.1111/jocd.13073

M3 - Article

C2 - 31310047

AN - SCOPUS:85069931848

JO - Journal of Cosmetic Dermatology

JF - Journal of Cosmetic Dermatology

SN - 1473-2130

ER -